News

Biogen statement following disclosure of EU list price for nusinersen

EU list price for nusinersenIn response to a request from SMA Europe, Biogen representatives and the board members of SMA Europe participated in a joint conference call on Friday 9th June, 2017 to discuss the EU list price for nusinersen.

Following a subsequent request to share a summary of the discussion, Biogen provided the following update.

For more information

Leave a Reply

Your email address will not be published. Required fields are marked *